378 related articles for article (PubMed ID: 29967939)
1. Sex-specific genetic predictors of Alzheimer's disease biomarkers.
Deming Y; Dumitrescu L; Barnes LL; Thambisetty M; Kunkle B; Gifford KA; Bush WS; Chibnik LB; Mukherjee S; De Jager PL; Kukull W; Huentelman M; Crane PK; Resnick SM; Keene CD; Montine TJ; Schellenberg GD; Haines JL; Zetterberg H; Blennow K; Larson EB; Johnson SC; Albert M; Moghekar A; Del Aguila JL; Fernandez MV; Budde J; Hassenstab J; Fagan AM; Riemenschneider M; Petersen RC; Minthon L; Chao MJ; Van Deerlin VM; Lee VM; Shaw LM; Trojanowski JQ; Peskind ER; Li G; Davis LK; Sealock JM; Cox NJ; ; ; Goate AM; Bennett DA; Schneider JA; Jefferson AL; Cruchaga C; Hohman TJ
Acta Neuropathol; 2018 Dec; 136(6):857-872. PubMed ID: 29967939
[TBL] [Abstract][Full Text] [Related]
2. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau.
Hohman TJ; Dumitrescu L; Barnes LL; Thambisetty M; Beecham G; Kunkle B; Gifford KA; Bush WS; Chibnik LB; Mukherjee S; De Jager PL; Kukull W; Crane PK; Resnick SM; Keene CD; Montine TJ; Schellenberg GD; Haines JL; Zetterberg H; Blennow K; Larson EB; Johnson SC; Albert M; Bennett DA; Schneider JA; Jefferson AL;
JAMA Neurol; 2018 Aug; 75(8):989-998. PubMed ID: 29801024
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.
Deming Y; Li Z; Kapoor M; Harari O; Del-Aguila JL; Black K; Carrell D; Cai Y; Fernandez MV; Budde J; Ma S; Saef B; Howells B; Huang KL; Bertelsen S; Fagan AM; Holtzman DM; Morris JC; Kim S; Saykin AJ; De Jager PL; Albert M; Moghekar A; O'Brien R; Riemenschneider M; Petersen RC; Blennow K; Zetterberg H; Minthon L; Van Deerlin VM; Lee VM; Shaw LM; Trojanowski JQ; Schellenberg G; Haines JL; Mayeux R; Pericak-Vance MA; Farrer LA; Peskind ER; Li G; Di Narzo AF; ; ; Kauwe JS; Goate AM; Cruchaga C
Acta Neuropathol; 2017 May; 133(5):839-856. PubMed ID: 28247064
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.
Han MR; Schellenberg GD; Wang LS;
BMC Neurol; 2010 Oct; 10():90. PubMed ID: 20932310
[TBL] [Abstract][Full Text] [Related]
5. GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.
Cruchaga C; Kauwe JS; Harari O; Jin SC; Cai Y; Karch CM; Benitez BA; Jeng AT; Skorupa T; Carrell D; Bertelsen S; Bailey M; McKean D; Shulman JM; De Jager PL; Chibnik L; Bennett DA; Arnold SE; Harold D; Sims R; Gerrish A; Williams J; Van Deerlin VM; Lee VM; Shaw LM; Trojanowski JQ; Haines JL; Mayeux R; Pericak-Vance MA; Farrer LA; Schellenberg GD; Peskind ER; Galasko D; Fagan AM; Holtzman DM; Morris JC; ; ; ; Goate AM
Neuron; 2013 Apr; 78(2):256-68. PubMed ID: 23562540
[TBL] [Abstract][Full Text] [Related]
6. Genome-Wide Meta-Analysis of Cerebrospinal Fluid Biomarkers in Alzheimer's Disease and Parkinson's Disease Cohorts.
Ta M; Blauwendraat C; Antar T; Leonard HL; Singleton AB; Nalls MA; Iwaki H;
Mov Disord; 2023 Sep; 38(9):1697-1705. PubMed ID: 37539664
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide association study for variants that modulate relationships between cerebrospinal fluid amyloid-beta 42, tau, and p-tau levels.
Maxwell TJ; Corcoran C; Del-Aguila JL; Budde JP; Deming Y; Cruchaga C; Goate AM; Kauwe JSK;
Alzheimers Res Ther; 2018 Aug; 10(1):86. PubMed ID: 30153862
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers.
Ramos de Matos M; Ferreira C; Herukka SK; Soininen H; Janeiro A; Santana I; Baldeiras I; Almeida MR; Lleó A; Dols-Icardo O; Alcolea D; Benussi L; Binetti G; Paterlini A; Ghidoni R; Nacmias B; Meulenbroek O; van Waalwijk van Doorn LJC; Kuiperi HBJ; Hausner L; Waldemar G; Simonsen AH; Tsolaki M; Gkatzima O; Resende de Oliveira C; Verbeek MM; Clarimon J; Hiltunen M; de Mendonça A; Martins M
J Alzheimers Dis; 2018; 66(2):639-652. PubMed ID: 30320580
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
11. High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.
Galasko D; Chang L; Motter R; Clark CM; Kaye J; Knopman D; Thomas R; Kholodenko D; Schenk D; Lieberburg I; Miller B; Green R; Basherad R; Kertiles L; Boss MA; Seubert P
Arch Neurol; 1998 Jul; 55(7):937-45. PubMed ID: 9678311
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers.
Jansen IE; van der Lee SJ; Gomez-Fonseca D; de Rojas I; Dalmasso MC; Grenier-Boley B; Zettergren A; Mishra A; Ali M; Andrade V; Bellenguez C; Kleineidam L; Küçükali F; Sung YJ; Tesí N; Vromen EM; Wightman DP; Alcolea D; Alegret M; Alvarez I; Amouyel P; Athanasiu L; Bahrami S; Bailly H; Belbin O; Bergh S; Bertram L; Biessels GJ; Blennow K; Blesa R; Boada M; Boland A; Buerger K; Carracedo Á; Cervera-Carles L; Chene G; Claassen JAHR; Debette S; Deleuze JF; de Deyn PP; Diehl-Schmid J; Djurovic S; Dols-Icardo O; Dufouil C; Duron E; Düzel E; ; Fladby T; Fortea J; Frölich L; García-González P; Garcia-Martinez M; Giegling I; Goldhardt O; Gobom J; Grimmer T; Haapasalo A; Hampel H; Hanon O; Hausner L; Heilmann-Heimbach S; Helisalmi S; Heneka MT; Hernández I; Herukka SK; Holstege H; Jarholm J; Kern S; Knapskog AB; Koivisto AM; Kornhuber J; Kuulasmaa T; Lage C; Laske C; Leinonen V; Lewczuk P; Lleó A; de Munain AL; Lopez-Garcia S; Maier W; Marquié M; Mol MO; Montrreal L; Moreno F; Moreno-Grau S; Nicolas G; Nöthen MM; Orellana A; Pålhaugen L; Papma JM; Pasquier F; Perneczky R; Peters O; Pijnenburg YAL; Popp J; Posthuma D; Pozueta A; Priller J; Puerta R; Quintela I; Ramakers I; Rodriguez-Rodriguez E; Rujescu D; Saltvedt I; Sanchez-Juan P; Scheltens P; Scherbaum N; Schmid M; Schneider A; Selbæk G; Selnes P; Shadrin A; Skoog I; Soininen H; Tárraga L; Teipel S; ; Tijms B; Tsolaki M; Van Broeckhoven C; Van Dongen J; van Swieten JC; Vandenberghe R; Vidal JS; Visser PJ; Vogelgsang J; Waern M; Wagner M; Wiltfang J; Wittens MMJ; Zetterberg H; Zulaica M; van Duijn CM; Bjerke M; Engelborghs S; Jessen F; Teunissen CE; Pastor P; Hiltunen M; Ingelsson M; Andreassen OA; Clarimón J; Sleegers K; Ruiz A; Ramirez A; Cruchaga C; Lambert JC; van der Flier W
Acta Neuropathol; 2022 Nov; 144(5):821-842. PubMed ID: 36066633
[TBL] [Abstract][Full Text] [Related]
13. Effects of Alzheimer's disease-associated risk loci on cerebrospinal fluid biomarkers and disease progression: a polygenic risk score approach.
Martiskainen H; Helisalmi S; Viswanathan J; Kurki M; Hall A; Herukka SK; Sarajärvi T; Natunen T; Kurkinen KM; Huovinen J; Mäkinen P; Laitinen M; Koivisto AM; Mattila KM; Lehtimäki T; Remes AM; Leinonen V; Haapasalo A; Soininen H; Hiltunen M
J Alzheimers Dis; 2015; 43(2):565-73. PubMed ID: 25096612
[TBL] [Abstract][Full Text] [Related]
14. Genetic loci associated with Alzheimer's disease and cerebrospinal fluid biomarkers in a Finnish case-control cohort.
Elias-Sonnenschein LS; Helisalmi S; Natunen T; Hall A; Paajanen T; Herukka SK; Laitinen M; Remes AM; Koivisto AM; Mattila KM; Lehtimäki T; Verhey FR; Visser PJ; Soininen H; Hiltunen M
PLoS One; 2013; 8(4):e59676. PubMed ID: 23573206
[TBL] [Abstract][Full Text] [Related]
15. Association Between Common Variants of APOE, ABCA7, A2M, BACE1, and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: Data from the PUMCH Dementia Cohort.
Dong L; Mao C; Liu C; Li J; Huang X; Wang J; Lei D; Chu S; Sha L; Xu Q; Peng B; Cui L; Gao J
J Alzheimers Dis; 2022; 85(4):1511-1518. PubMed ID: 34958020
[TBL] [Abstract][Full Text] [Related]
16. A Non-APOE Polygenic Risk Score for Alzheimer's Disease Is Associated With Cerebrospinal Fluid Neurofilament Light in a Representative Sample of Cognitively Unimpaired 70-Year Olds.
Skoog I; Kern S; Najar J; Guerreiro R; Bras J; Waern M; Zetterberg H; Blennow K; Zettergren A
J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):983-990. PubMed ID: 33512503
[TBL] [Abstract][Full Text] [Related]
17. Interactions between apolipoprotein E, sex, and amyloid-beta on cerebrospinal fluid p-tau levels in the European prevention of Alzheimer's dementia longitudinal cohort study (EPAD LCS).
Saunders TS; Jenkins N; Blennow K; Ritchie C; Muniz-Terrera G
EBioMedicine; 2022 Sep; 83():104241. PubMed ID: 36041266
[TBL] [Abstract][Full Text] [Related]
18. Biomarker profiles of Alzheimer's disease and dynamic of the association between cerebrospinal fluid levels of β-amyloid peptide and tau.
Lafirdeen ASM; Cognat E; Sabia S; Hourregue C; Lilamand M; Dugravot A; Bouaziz-Amar E; Laplanche JL; Hugon J; Singh-Manoux A; Paquet C; Dumurgier J
PLoS One; 2019; 14(5):e0217026. PubMed ID: 31086391
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
[TBL] [Abstract][Full Text] [Related]
20. Sex differences in the genetic predictors of Alzheimer's pathology.
Dumitrescu L; Barnes LL; Thambisetty M; Beecham G; Kunkle B; Bush WS; Gifford KA; Chibnik LB; Mukherjee S; De Jager PL; Kukull W; Crane PK; Resnick SM; Keene CD; Montine TJ; Schellenberg GD; Deming Y; Chao MJ; Huentelman M; Martin ER; Hamilton-Nelson K; Shaw LM; Trojanowski JQ; Peskind ER; Cruchaga C; Pericak-Vance MA; Goate AM; Cox NJ; Haines JL; Zetterberg H; Blennow K; Larson EB; Johnson SC; Albert M; ; Bennett DA; Schneider JA; Jefferson AL; Hohman TJ
Brain; 2019 Sep; 142(9):2581-2589. PubMed ID: 31497858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
